Maxine Gowen

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Matthew Rothman, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Maxine Gowen

Form 4 holding Director

Merus N.V.

Security class
Share Option (right to buy)
Shares / value
0
Estimated value
$119,571
Report date
12 Dec 2025
Price
$13.52
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Passage BIO, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
10,539
Estimated value
Report date
19 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aceragen, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
10 Aug 2023
Price
$0.5100
Ownership
By Trust

Insider Reports Filed by Maxine Gowen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .